Parmax Pharma informs about trading window closure

30 Dec 2025 Evaluate
In terms of provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and Company’s Code of Conduct to regulate, monitor and report trading by Designated Persons, Parmax Pharma has informed that the Trading Window for dealing in securities of the Company by Designated Persons shall remain closed from January 01, 2026 till 48 hours after the declaration of the financial results for the quarter ending on December 31, 2025 for all designated persons of the Company. The date of the Board Meeting at which the said results will be considered shall be intimated in due course of time.

The above information is a part of company’s filings submitted to BSE.

Parmax Pharma Share Price

35.04 0.52 (1.51%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×